default author photo

Lauren Ostermann

University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia

SCHOLARLY PAPERS

2

DOWNLOADS

143

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

E-Selectin Inhibition Overcomes Endothelial Niche-Mediated Resistance to Bcl-2–Targeted Therapy in AML

Number of pages: 27 Posted: 20 Oct 2022
University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, GlycoMimetics Inc, GlycoMimetics Inc, University of Texas at Houston - Section of Molecular Hematology and Therapy and University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia
Downloads 91 (736,406)

Abstract:

Loading...

acute myeloid leukemia, leukemia stem cells, E-selectin, Bcl-2, antagonist

2.

Age-Specific Induction of Mutant p53 in Hematopoietic Stem Cells Drives Clonal Hematopoiesis in Adult Mice Leading to Acute Myeloid Leukemia

Number of pages: 44 Posted: 30 Aug 2023
University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, The Francis Crick Institute - Cancer Genomics Laboratory, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Department of Epigenetics and Molecular Carcinogenesis, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Nebraska at Omaha - Department of Pathology and Microbiology, University of Texas at Houston - Department of Veterinary Medicine and Surgery, The Francis Crick Institute - Cancer Genomics Laboratory and University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia
Downloads 52 (1,086,013)

Abstract:

Loading...

TP53 mutations, Clonal hematopoiesis (CH), Acute myeloid leukemia (AML), Mdm2 haploinsufficiency, Myeloid-biased hematopoiesis, Hematopoietic stem cells